gpASIT+TM/Immunoregulating Adjuvant
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for gpASIT+TM/Immunoregulating Adjuvant, covering 2011-03-01 to 2011-03-01. Get the full timeline:
Most recent: Clinical Trial Update: Clinical Safety and Tolerability Study of gpASIT+TM and gpASIT+TM/Immunoregulating Adjuvant to Treat Seasonal Grass Pollen Rhinoconjunctivitis [Phase 1]